Lates News

According to the latest news from Every Macro AI, Dongguan Securities issued a research report on August 28, giving a buy rating to Yifeng Pharmacy (603939.SH). The main reasons for the rating include: 1) the slowing down of store expansion speed; 2) continuous advancement in online business development; 3) improvement in gross profit margin and net profit margin. (Daily Economic News)